Bioneer Corporation

KOSDAQ:A064550 Stock Report

Market Cap: ₩491.2b

Bioneer Past Earnings Performance

Past criteria checks 0/6

Bioneer's earnings have been declining at an average annual rate of -28.9%, while the Biotechs industry saw earnings growing at 2.7% annually. Revenues have been growing at an average rate of 21.9% per year.

Key information

-28.9%

Earnings growth rate

-28.1%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate21.9%
Return on equity-10.6%
Net Margin-9.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Nov 28
Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Recent updates

Investors Don't See Light At End Of Bioneer Corporation's (KOSDAQ:064550) Tunnel And Push Stock Down 26%

Nov 14
Investors Don't See Light At End Of Bioneer Corporation's (KOSDAQ:064550) Tunnel And Push Stock Down 26%

Bioneer Corporation's (KOSDAQ:064550) 27% Dip In Price Shows Sentiment Is Matching Revenues

Sep 06
Bioneer Corporation's (KOSDAQ:064550) 27% Dip In Price Shows Sentiment Is Matching Revenues

Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Jul 11
Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Mar 06
Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly

Mar 25
Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly

Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 15
Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%

Jan 20
Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%

Is Bioneer (KOSDAQ:064550) A Risky Investment?

Dec 24
Is Bioneer (KOSDAQ:064550) A Risky Investment?

Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Nov 28
Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Revenue & Expenses Breakdown

How Bioneer makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A064550 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24287,658-26,655203,87920,191
30 Jun 24295,518-16,196202,69819,709
31 Mar 24286,423-10,948196,69816,792
31 Dec 23263,237-10,587181,74615,031
30 Sep 23248,909-3,698170,41913,750
30 Jun 23229,7594,476153,11013,447
31 Mar 23212,9702,917140,47116,275
31 Dec 22218,39412,077134,22316,751
30 Sep 22224,37223,194129,71317,881
30 Jun 22233,7684,807142,08218,640
31 Mar 22235,31620,688122,43918,470
31 Dec 21223,74427,160105,27417,987
30 Sep 21229,39456,88986,18917,169
30 Jun 21239,10269,27454,99915,148
31 Mar 21244,26594,01150,62314,469
31 Dec 20206,98757,89940,33513,118
30 Sep 20152,90120,00832,39411,354
30 Jun 2090,31515,94622,22811,943
31 Mar 2042,113-26,06114,43710,963
31 Dec 1936,292-7,82712,80510,985
30 Sep 1936,252-7,05111,97911,679
30 Jun 1930,917-8,17511,21111,187
31 Mar 1926,523-8,15311,80510,675
31 Dec 1824,078-8,81811,12810,420
30 Sep 1822,570-11,26410,15410,580
30 Jun 1822,863-10,1879,7509,617
31 Mar 1821,744-10,7898,7039,022
31 Dec 1723,268-9,9418,2468,071
30 Sep 1723,953-7,9078,9908,293
30 Jun 1722,961-12,38611,2237,803
31 Mar 1723,085-15,05812,1958,232
31 Dec 1621,704-15,37812,7938,468
30 Sep 1621,244-14,12312,0826,825
30 Jun 1621,895-8,3649,5736,744
31 Mar 1621,182-5,5787,6346,026
31 Dec 1520,834-5,3727,6486,014
30 Sep 1520,193-6,4948,5205,711
30 Jun 1518,616-10,66011,6054,358
31 Mar 1517,858-14,06312,7084,786
31 Dec 1417,854-13,55910,7875,880
30 Sep 1417,820-14,24810,3845,947
30 Jun 1419,923-13,16610,4495,947
31 Mar 1422,179-9,0569,7575,988
31 Dec 1323,904-7,1529,4465,747

Quality Earnings: A064550 is currently unprofitable.

Growing Profit Margin: A064550 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A064550 is unprofitable, and losses have increased over the past 5 years at a rate of 28.9% per year.

Accelerating Growth: Unable to compare A064550's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A064550 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.9%).

Return on Equity

High ROE: A064550 has a negative Return on Equity (-10.65%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 03:26
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioneer Corporation is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiwoo BaekShinhan Investment Corp.
Choongwoo SeoSK Securities Co., Ltd.
Mihwa SeoYuanta Securities Korea Co., Ltd.